Error Correction [Text Block] | NOTE 2: RESTATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS Subsequent to the filing of our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021, management identified certain restatements and other immaterial revisions. Fair Value Restatements In January 2021, the Company purchased corporate investments that consisted of unsecured convertible debentures and purchase warrants. As a result of additional analysis of the fair value of these corporate investments, the purchase price of the corporate investments was reallocated to the unsecured convertible debentures and purchase warrants at the acquisition date, and the fair value of the unsecured convertible debentures was understated by $7.5 million, and the fair value of purchase warrants was overstated by $1.7 million at March 31, 2021. The impact of these corrections to previously reported financial statements is an increase in employee compensation and benefits expense of $60,000, a decrease to investment income of $7.1 million, a decrease to net income of $5.6 million, a decrease in basic and diluted earnings per share of $0.37, and an increase in other comprehensive income net of tax of $10.1 million for the three and nine months ended March 31, 2021. The impact to the balance sheet is a net increase in investments of $5.8 million, a net increase in liabilities of $1.2 million, and an increase in equity of $4.5 million. As a result of this, Note 4 has been updated to include disclosures related to level 3 measurements. Other Immaterial Revisions The Company was granted forgiveness of its Paycheck Protection Program ("PPP") loan and accrued interest totaling $444,000 in the quarter ended December 31, 2020. The Company recorded the extinguishment of debt related to the forgiveness as other operating revenue instead of other income in both the December 31, 2020, and the March 31, 2021, financial statements. This revision has no impact on net income or earnings per share and was deemed immaterial. Since the Company is restating the March 31, 2021, Form 10-Q, the reclassification of the PPP loan forgiveness is included in the restated Form 10-Q/A. For the quarter and nine months ended March 31, 2021, the line-item other operating revenue was removed, and the line-item gain on forgiveness of PPP loan was added to other income. For comparative purposes, the unaudited interim financial statements for the quarter and six months ended December 31, 2020 will include the reclassification when presented. In addition, the Company recorded changes in the fair value of investment securities and sales of short-term investments within “Changes in operating assets and liabilities” on the statement of cash flows in prior periods instead of within “Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities” and “Cash flows from investing activities,” respectively. These revisions had no impact on net income or earnings per share and were deemed immaterial. Since the Company is restating the March 31, 2021, Form 10-Q, the revisions are included in the restated Form 10-Q/A. Accordingly, the line-item “Investment securities” was removed, and the balances were reclassified to unrealized investment (gains) losses on securities and proceeds on sales of current investments. For comparative purposes, the unaudited interim financial statements of prior periods will include the reclassification when presented. For the quarter ended September 30, 2020, ($994,000) will be reclassified from investment securities to unrealized investment gains on securities. For the six months ended December 31, 2020, ($6.5 million) will be reclassified from investment securities to unrealized investment gains on securities. Impact of Restatement Adjustments on Unaudited Quarterly Financial Statements The effects of the restatement on our unaudited consolidated financial statements as of and for the three and nine months ended March 31, 2021, and on our unaudited statement of cash flows for the nine months ended March 31, 2020, are set forth as follows. CONSOLIDATED BALANCE SHEETS March 31, 2021 Assets (unaudited) (dollars in thousands) As Restatement Adjustments As Current Assets Cash and cash equivalents $ 9,479 $ - $ 9,479 Restricted cash 1,000 - 1,000 Investments in securities at fair value 6,322 - 6,322 Accounts and other receivables 2,645 - 2,645 Prepaid expenses 430 - 430 Total Current Assets 19,876 - 19,876 Net Property and Equipment 1,388 - 1,388 Other Assets Investments in equity securities at fair value, non-current 18,635 (1,696 ) 16,939 Investments in available-for-sale debt securities at fair value 16,470 7,457 23,927 Other investments 2,940 - 2,940 Investments in held-to-maturity debt securities 1,000 - 1,000 Equity method investments 596 - 596 Right of use assets 56 - 56 Other assets, non-current 100 - 100 Total Other Assets 39,797 5,761 45,558 Total Assets $ 61,061 $ 5,761 $ 66,822 Liabilities and Shareholders Equity Current Liabilities Accounts payable $ 72 $ - $ 72 Accrued compensation and related costs 692 55 747 Dividends payable 226 - 226 Lease liability, short-term 52 - 52 Other accrued expenses 1,221 5 1,226 Taxes payable 3,515 (43 ) 3,472 Note payable, current - - - Total Current Liabilities 5,778 17 5,795 Long-Term Liabilities Deferred tax liability 4,681 1,216 5,897 Lease liability, long-term 4 - 4 Total Long-Term Liabilities 4,685 1,216 5,901 Total Liabilities 10,463 1,233 11,696 Commitments and Contingencies Shareholders Equity Common stock (class A) - $0.025 par value; nonvoting; authorized, 28,000,000 shares; issued, 13,866,913 shares at March 31, 2021, and June 30, 2020 347 - 347 Common stock (class B) - $0.025 par value; nonvoting; authorized, 4,500,000 shares; no shares issued - - - Convertible common stock (class C) - $0.025 par value; voting; authorized, 3,500,000 shares; issued, 2,068,635 shares at March 31, 2021, and June, 30, 2020 52 - 52 Additional paid-in-capital 15,628 - 15,628 Treasury stock, class A shares at cost; 883,326 shares and 855,432 shares at March 31, 2021, and June 30, 2020, respectively (2,051 ) - (2,051 ) Accumulated other comprehensive income (loss), net of tax 1,695 10,145 11,840 Retained earnings 34,927 (5,617 ) 29,310 Total Shareholders Equity 50,598 4,528 55,126 Total Liabilities and Shareholders Equity $ 61,061 $ 5,761 $ 66,822 CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Nine Months Ended March 31, 2021 Three Months Ended March 31, 2021 (dollars in thousands, except per share data) As Restatement Adjustments Other Immaterial Revisions As As Restatement Adjustments As Operating Revenues Advisory fees $ 14,168 $ - $ - $ 14,168 $ 6,304 $ - $ 6,304 Administrative services fees 153 - - 153 51 - 51 Other operating revenue 444 - (444 ) - - - - 14,765 - (444 ) 14,321 6,355 - 6,355 Operating Expenses Employee compensation and benefits 5,582 60 - 5,642 1,382 60 1,442 General and administrative 4,066 - - 4,066 1,528 - 1,528 Advertising 162 - - 162 44 - 44 Depreciation and amortization 147 - - 147 49 - 49 9,957 60 - 10,017 3,003 60 3,063 Operating Income (Loss) 4,808 (60 ) (444 ) 4,304 3,352 (60 ) 3,292 Other Income (Loss) Investment income 37,205 (7,081 ) - 30,124 15,505 (7,081 ) 8,424 Income (loss) from equity method investments 420 - - 420 (64 ) - (64 ) Gain on forgiveness of PPP loan - - 444 444 - - - Other income 92 - - 92 33 - 33 37,717 (7,081 ) 444 31,080 15,474 (7,081 ) 8,393 Income from Continuing Operations Before Income Taxes 42,525 (7,141 ) - 35,384 18,826 (7,141 ) 11,685 Provision for Income Taxes Tax expense (benefit) 9,696 (1,524 ) - 8,172 4,602 (1,524 ) 3,078 Net Income 32,829 (5,617 ) - 27,212 14,224 (5,617 ) 8,607 Net Income Attributable to U.S. Global Investors, Inc. $ 32,829 $ (5,617 ) $ - $ 27,212 $ 14,224 $ (5,617 ) $ 8,607 Earnings Per Share Attributable to U.S. Global Investors, Inc. Basic Net Income per Share $ 2.18 $ (0.37 ) $ - $ 1.81 $ 0.94 $ (0.37 ) $ 0.57 Diluted Net Income per Share $ 2.18 $ (0.37 ) $ - $ 1.81 $ 0.94 $ (0.37 ) $ 0.57 Basic weighted average number of common shares outstanding 15,075,064 15,075,064 15,061,818 15,061,818 Diluted weighted average number of common shares outstanding 15,075,795 15,075,795 15,062,988 15,062,988 CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) Nine Months Ended March 31, 2021 Three Months Ended March 31, 2021 (dollars in thousands) As Restatement As As Restatement As Net Income (Loss) Attributable to U.S. Global Investors, Inc. $ 32,829 $ (5,617 ) $ 27,212 $ 14,224 $ (5,617 ) $ 8,607 Other Comprehensive Income, Net of Tax: Unrealized gains on available-for-sale securities arising during period 1,681 10,581 12,262 1,681 10,581 12,262 Less: reclassification adjustment for gains included in net income - (436 ) (436 ) - (436 ) (436 ) Net change from available-for-sale securities, net of tax 1,681 10,145 11,826 1,681 10,145 11,826 Foreign currency translation adjustment 18 - 18 6 - 6 Other Comprehensive Income 1,699 10,145 11,844 1,687 10,145 11,832 Comprehensive Income Attributable to U.S. Global Investors, Inc. $ 34,528 $ 4,528 $ 39,056 $ 15,911 $ 4,528 $ 20,439 CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (UNAUDITED) Balance at March 31, 2021 (dollars in thousands) As Previously Reported Restatement Adjustments As Restated Accumulated Other Comprehensive Income (Loss) $ 1,695 $ 10,145 $ 11,840 Retained Earnings $ 34,927 $ (5,617 ) $ 29,310 Total $ 50,598 $ 4,528 $ 55,126 CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Nine Months Ended March 31, 2021 (dollars in thousands) As Restatement Adjustments Other Immaterial Revisions As Restated Cash Flows from Operating Activities: Net income (loss) $ 32,829 $ (5,617 ) $ - $ 27,212 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization 147 - - 147 Net recognized loss on disposal of fixed assets 7 - - 7 Net recognized gain on securities (15,506 ) - - (15,506 ) Amortization of premium on debt securities - 83 - 83 Accretion of discount on debt securities - (552 ) - (552 ) Unrealized investment (gains) losses on securities - 7,550 (21,226 ) (13,676 ) Investment basis adjustment 27 - - 27 Gain on disposal of Galileo - - - - Net (income) loss from equity method investment (420 ) - - (420 ) Net loss from discontinued operations, net of tax - - - - Foreign currency transaction loss - - - - Provision for deferred taxes 4,234 (1,481 ) - 2,753 Stock bonuses 18 - - 18 PPP loan forgiveness (444 ) - - (444 ) Changes in operating assets and liabilities: Accounts receivable and other receivables (1,671 ) - - (1,671 ) Prepaid expenses and other assets (117 ) - - (117 ) Investment securities (21,226 ) - 21,226 - Accounts payable and accrued expenses 4,062 17 - 4,079 Total adjustments (30,889 ) 5,617 - (25,272 ) Net cash provided by operating activities 1,940 - - 1,940 Cash Flows from Investing Activities: Purchase of property and equipment (36 ) - - (36 ) Purchase of investments in securities at fair value, non-current (135 ) (5,853 ) - (5,988 ) Purchase of other investments (665 ) - - (665 ) Purchase of held-to-maturity investments (1,000 ) - - (1,000 ) Purchase of available-for-sale investments (15,000 ) 5,853 - (9,147 ) Proceeds from sale of Galileo - - - - Proceeds on sale of non-current investments 22,355 - - 22,355 Proceeds from maturity of corporate bonds 658 - - 658 Return of capital on investments - - - - Net cash provided by investing activities 6,177 - - 6,177 Cash Flows from Financing Activities: Issuance of common stock 4 - - 4 Repurchases of common stock (189 ) - - (189 ) Dividends paid (414 ) - - (414 ) Net cash used in financing activities (599 ) - - (599 ) Net increase in cash, cash equivalents, and restricted cash 7,518 - - 7,518 Beginning cash, cash equivalents, and restricted cash 2,961 - - 2,961 Ending cash, cash equivalents, and restricted cash $ 10,479 $ - $ - $ 10,479 Supplemental Disclosures of Cash Flow Information Cash paid for income taxes $ 1,902 $ 1,902 CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (CONTINUED) Nine Months Ended March 31, 2020 (dollars in thousands) As Other Immaterial Revisions As Restated Cash Flows from Operating Activities: Net loss $ (6,300 ) $ - $ (6,300 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization 152 - 152 Unrealized investment losses on securities - 3,995 3,995 Investment basis adjustment (49 ) - (49 ) Gain on disposal of Galileo (151 ) - (151 ) Net loss from equity method investment 146 - 146 Net loss from discontinued operations, net of tax 338 - 338 Foreign currency transaction loss 228 - 228 Provision for deferred taxes (139 ) - (139 ) Stock bonuses 3 - 3 Changes in operating assets and liabilities: Accounts receivable and other receivables 108 - 108 Prepaid expenses and other assets (148 ) - (148 ) Investment securities 5,707 (5,707 ) - Accounts payable and accrued expenses 456 - 456 Total adjustments 6,651 (1,712 ) 4,939 Net cash provided by (used in) operating activities 351 (1,712 ) (1,361 ) Cash Flows from Investing Activities: Purchase of other investments (75 ) - (75 ) Proceeds from sale of Galileo 746 - 746 Proceeds on sale of current investments - 1,712 1,712 Return of capital on investments 10 - 10 Net cash provided by investing activities 681 1,712 2,393 Cash Flows from Financing Activities: Issuance of common stock 2 - 2 Repurchases of common stock (74 ) - (74 ) Dividends paid (340 ) - (340 ) Net cash used in financing activities (412 ) - (412 ) Net increase in cash, cash equivalents, and restricted cash 620 - 620 Beginning cash, cash equivalents, and restricted cash 2,491 - 2,491 Ending cash, cash equivalents, and restricted cash $ 3,111 $ - $ 3,111 |